BRISTOL-MYERS SQUIBB Stockholder Information

Common Stock Form 10-K Product Names and Company Programs Ticker symbol: BMY For a free copy of the Company’s Annual Global products and company program Stock Exchange Report on Form 10-K for the fiscal year names appearing throughout in italics ended December 31, 2018, contact: are referred to herein by their registered Stockholder Services and approved U.S. trademarks, unless Corporate Secretary specifically noted otherwise. All inquiries concerning stockholder Bristol-Myers Squibb Company accounts and stock transfer matters – 430 E. 29th Street, 14FL Abilify is a trademark of Otsuka including address changes, the New York, NY 10016 Pharmaceutical Co., Ltd. elimination of duplicate mailings and The Form 10-K is also available at the Shareowner Services Plus PlanSM – Adcetris is a trademark of Seattle investor.bms.com. should be directed to the Company’s Genetics, Inc. Transfer Agent and Registrar: The most recent certifications by the Atripla, Truvada, and Tybost are trademarks Company’s chief executive officer and chief of , Inc. and/or one EQ Shareowner Services financial officer pursuant to Section 302 of of its affiliates. 1110 Centre Pointe Curve, Suite 101 the Sarbanes-Oxley Act of 2002 are filed as Mendota Heights, MN 55120-4100 exhibits to the Company’s Form 10-K. The Avapro/Avalide (known in the EU Company has also filed with the New York as Aprovel/Karvea) and Plavix are www.shareowneronline.com Stock Exchange the most recent Annual trademarks of CEO Certification as required by Section 855-598-5485 (within the U.S.) Byetta is a trademarks of Amylin 651-450-4064 (outside the U.S.) 303A.12(a) of the Pharmaceuticals, LLC Listed Company Manual. A telecommunications relay service should ENHANZE is a trademark of , Inc. be used by the hearing impaired when Additional Information calling the telephone numbers above. Erbitux is a trademark of ImClone LLC Information on the following subjects and are trademarks of Shareowner Services Plus PlanSM is available at www.bms.com: Farxiga Onglyza AstraZeneca AB The Shareowner Services Plus PlanSM is • Bristol-Myers Squibb Foundation designed for long-term investors who wish • Clinical Trials Gleevec is a trademark of Novartis AG to build share ownership in the Company’s • Compliance and Ethics Ixempra is a trademark of R-Pharm common stock over time. You can partici- • Diversity and Workforce Statistics US Operating, LLC pate in the plan if you are a registered holder of the Company’s common stock. If you do • Patient Assistance Programs Keytruda is a trademark of Merck Sharp not own the Company’s common stock, you • Policy and Advocacy Engagement & Dohme Corp. and Political Contributions can become a participant by making your Prostvac is a trademark of BN initial purchase through the plan. The plan • Sustainability/Environmental Programs ImmunoTherapeutics Inc. features dividend reinvestment, optional cash purchase, share safekeeping, and This Annual Report contains certain SECURE THE FUTURE is trademark of share sales and transfers. Bristol-Myers forward-looking information within the Bristol-Myers Squibb. Squibb Company has appointed EQ Share- meaning of the Private Securities Litigation Brand names of products that are in all owner Services as Administrator for the plan. Reform Act of 1995. These forward-looking italicized letters, without an asterisk, are The plan is not sponsored or administered statements are based on current expec- registered trademarks of Bristol-Myers by Bristol-Myers Squibb Company. tations and involve inherent risks and Squibb and/or one of its subsidiaries. uncertainties that could cause actual out- comes and results to differ materially from current expectations. Please see page 26 in the Financial Review for a discussion and description of these risks and uncertainties. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Shareowner Services Plus Plan is a Service Mark of EQ Shareowner Services.